Past, imminent and future human medical countermeasures for anthrax.
about
Analysis of antibody responses to protective antigen-based anthrax vaccines through use of competitive assaysAntitoxin Treatment of Inhalation Anthrax: A Systematic ReviewAerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatmentEfficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthraxPoint-of-care testing for pandemic influenza and biothreats.High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation.Anthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine.Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1.Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategyMapping the epitopes of a neutralizing antibody fragment directed against the lethal factor of Bacillus anthracis and cross-reacting with the homologous edema factorAnthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunityAntibodies against anthrax: mechanisms of action and clinical applications.Natural cutaneous anthrax infection, but not vaccination, induces a CD4(+) T cell response involving diverse cytokinesA novel immunogenic spore coat-associated protein in Bacillus anthracis: characterization via proteomics approaches and a vector-based vaccine system.Soluble Expression and Characterization of Biologically Active Bacillus anthracis Protective Antigen in Escherichia coli.Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism.Efficient neutralization of antibody-resistant forms of anthrax toxin by a soluble receptor decoy inhibitorUnique Inflammatory Mediators and Specific IgE Levels Distinguish Local from Systemic Reactions after Anthrax Vaccine Adsorbed VaccinationNovel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains.Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.Anthrax lethal toxin and the induction of CD4 T cell immunity.Glycan surface antigens from Bacillus anthracis as vaccine targets: current status and future perspectives.Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.Deterministic models of inhalational anthrax in New Zealand white rabbits.
P2860
Q28383562-506ACCC4-4B2B-4CE3-8109-98B214C8DF28Q28383765-9FEE6B52-7189-4CBB-A778-7E1EEAA543E8Q28385233-378FD4AF-F0CF-4799-8E56-41CB4D2151B3Q28389738-1C0B0516-A298-4E7D-98F1-103D74EFBB87Q30227516-16BD250C-CC5B-4CE7-B39C-5F941C40BF5DQ33285349-06D35873-8205-41BA-9D72-EE133C6146A4Q33505445-9F9AD50D-27C3-46CD-9427-7B71297BF4BFQ33665793-1E2F1259-F0D0-4A75-91A8-CCF89807FEF1Q34025527-103EAE46-8613-4229-9EBA-CC6DC38C618DQ34761514-537E1AD1-D233-4C59-9CA7-77449E76D29FQ35161514-7122C6A4-3211-4C55-9036-E42334654C8FQ35610439-8E5143AD-4DEE-4B14-AB02-B8720B59D36EQ35726627-D1F5D078-B950-42E0-93E0-F6C5B83DC9C8Q36328022-CB41A727-6FED-48EB-ACD2-EC73DFC0E92AQ36600600-7A437414-5DE6-458C-BEEF-71AF10929068Q36901955-A1B3895F-2D76-4529-8ED3-BB564DAF6B6CQ37115804-032FED5D-F645-47D7-988C-D3A676F9D6D3Q37163693-3E698C01-6745-416C-A589-7210861DE269Q37392700-17AF9EC9-896E-4BEA-8F23-DEFD45BC5FF2Q37404847-2DE4BB79-913A-4929-8D4E-4580F4C36C53Q38060730-81CA1331-4369-496B-9C94-484C260BE103Q38215454-199EC7AD-ADBC-4BF2-A89A-187F5BBFEBF0Q39143157-B2EC543D-844F-46DB-9E4C-1BFD2DE18AE8Q41977427-23CB544B-FA7C-46F3-B2B3-D6D67DD8A846
P2860
Past, imminent and future human medical countermeasures for anthrax.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Past, imminent and future human medical countermeasures for anthrax.
@ast
Past, imminent and future human medical countermeasures for anthrax.
@en
type
label
Past, imminent and future human medical countermeasures for anthrax.
@ast
Past, imminent and future human medical countermeasures for anthrax.
@en
prefLabel
Past, imminent and future human medical countermeasures for anthrax.
@ast
Past, imminent and future human medical countermeasures for anthrax.
@en
P2860
P1476
Past, imminent and future human medical countermeasures for anthrax.
@en
P2093
Baillie LW
P2860
P304
P356
10.1111/J.1365-2672.2006.03112.X
P577
2006-09-01T00:00:00Z